IDYA

IDEAYA Biosciences, Inc.

$36.01 +0.08 (+0.22%) At close · Jul 17

Market Cap

$3.16B

87,860,920

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$700,000	—	—	$8,418,840	$378,000	$15,800	$9,512,640
Joshua Bleharski	CFO	$333,333	$150,000	—	$3,463,975	$186,000	$14,014	$4,147,322
Darrin M. Beaupre	Chief Medical Officer	$526,500	—	—	$2,595,809	$196,000	$15,800	$3,334,109
Michael White	Chief Scientific Officer	$519,000	—	—	$2,595,809	$193,500	$15,800	$3,324,109
Andres Ruiz Briseno	Chief Accounting Officer	$417,000	—	—	$1,052,355	$168,000	$15,800	$1,653,155
Douglas B. Snyder	Chief Legal Officer	$440,000	—	—	$463,036	$164,000	$64,523	$1,131,560

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$646,000	—	—	$15,946,272	$323,000	$15,600	$16,930,872
Darrin M. Beaupre	Chief Medical Officer	$501,500	—	—	$5,315,424	$228,100	$15,600	$6,060,624
Michael White	Chief Scientific Officer	$489,500	—	—	$4,650,996	$223,300	$15,600	$5,379,396
Jason S. Throne	Chief Legal Officer and Corporate Secretary	$286,210	—	—	$4,169,286	—	$14,775	$4,470,270
Stuart C. Dorman	Chief Commercial Officer	$41,667	$100,000	—	$3,258,441	$20,000	$150	$3,420,258
Andres Ruiz Briseno	Chief Accounting Officer	$382,500	—	—	$2,823,819	$133,875	$15,600	$3,355,794

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$598,000	—	—	$5,083,440	$299,000	$15,000	$5,995,440
Michael White	Chief Scientific Officer	$462,000	—	—	$2,096,919	$184,800	$15,000	$2,758,719
Paul A. Stone	CFO	$432,024	—	—	$1,779,204	—	$14,775	$2,226,003
Jason S. Throne	Chief Legal Officer and Corporate Secretary	$417,000	—	—	$1,270,860	$166,800	$15,000	$1,869,660
Darrin M. Beaupre	Chief Medical Officer	$473,000	—	—	$1,143,774	$189,200	$3,377	$1,809,351
Andres Ruiz Briseno	Chief Accounting Officer	$345,000	—	—	$927,417	$125,125	$15,000	$1,412,542

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$570,000	—	—	$2,475,304	$270,750	$10,950	$3,327,004
Darrin M. Beaupre	Chief Medical Officer	$52,487	$100,000	—	$2,380,122	—	$150	$2,532,759
Michael White	Chief Scientific Officer	$440,000	—	—	$880,637	$169,840	$4,009	$1,494,486
Paul A. Stone	CFO	$419,000	—	—	$880,637	$161,734	$10,950	$1,472,321

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$543,600	—	—	$3,050,151	$244,620	$10,500	$3,848,871
Michael White	Chief Scientific Officer	$80,625	$180,000	—	$3,321,860	—	$375	$3,582,860
Paul A. Stone	CFO	$394,000	—	—	$1,251,344	$146,940	$10,500	$1,802,784

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$509,800	—	—	$1,066,486	$191,175	$10,350	$1,777,811
Jason S. Throne	General Counsel	$332,500	—	—	$738,233	$89,513	$3,550	$1,163,796
Paul A. Stone	CFO	$374,500	—	—	$396,832	$123,585	$10,350	$905,267

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$457,150	—	—	$1,398,696	$154,943	$10,200	$2,020,989
Julie Hambleton	Senior Vice President and Chief Medical Officer, Head of Development	$387,063	—	—	$180,964	$108,500	$10,200	$686,726
Michael P. Dillon	Senior Vice President and Chief Scientific Officer, Head of Research	$338,875	—	—	$226,205	$95,500	$10,200	$670,780
Paul A. Stone	CFO	$327,250	—	—	$180,964	$103,000	$1,800	$613,014

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	CEO	$420,000	—	—	$1,687,701	$147,000	$8,000	$2,262,701
Julie Hambleton	Senior Vice President and Chief Medical Officer, Head of Development	$218,750	—	—	$512,217	$65,625	$1,050	$797,642
Michael P. Dillon	Senior Vice President and Chief Scientific Officer, Head of Research	$315,000	—	—	$244,039	$94,500	$4,506	$658,045

Key facts CIK 1676725 CUSIP 45166A102 13F (30d) 18 filings 18 filers Visit website Investor relations